Tag: Veltassa

NICE u-turn backs NHS use of Veltassa

by Selina McKee | Dec 16, 2019 | News | 0

The drug will be funded on the NHS to treat hyperkalaemia

NICE turns down hyperkalaemia therapies

by Selina McKee | Oct 29, 2018 | News | 0

Preliminary guidelines released by the National Institute for Health and Care Excellence do not recommend NHS funding for hyperkalaemia treatments Lokelma and Veltassa.

Four new medicines cleared for use on NHS Scotland

by Selina McKee | Aug 14, 2018 | News | 0

The Scottish Medicines Consortium has approved funding for four newly licensed medicines, expanding NHS treatments options in Scotland for ovarian cancer, lung cancer, urea cycle disorders and acute hereditary angioedema.

EU nod for Vifor’s Veltassa

by Selina McKee | Jul 21, 2017 | News | 0

European regulators have approved Vifor Pharma’s new potassium binder Veltassa to treat hyperkalaemia in adult patients.

Eleven therapies put forward for EU approval

by Selina McKee | May 22, 2017 | News | 0

Eleven new medicines have been put forward for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including new options for a rare eye disease, schizophrenia and cartilage defects.